Assembly Biosciences

$6.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.30 (+5.26%) Today
+$0.04 (+0.67%) As of 7:00 AM EST after-hours

Why Robinhood?

You can buy or sell ASMB and other stocks, options, and ETFs commission-free!

About ASMB

Assembly Biosciences, Inc. Common Stock, also called Assembly Biosciences, is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA. The listed name for ASMB is Assembly Biosciences, Inc. Common Stock.

CEO
John G. McHutchison
Employees
115
Headquarters
South San Francisco, California
Founded
2005
Market Cap
198.13M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.60M
High Today
$6.14
Low Today
$5.79
Open Price
$5.80
Volume
1.25M
52 Week High
$27.84
52 Week Low
$4.78

Collections

ASMB Earnings

-$1.15
-$0.70
-$0.26
$0.19
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.75 per share
Actual
-$0.09 per share

You May Also Like